Ane Ogbe

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Rebecca Payne, Stephanie Longet, James Austin et al. · Cell · 2021 · 345 citations · Full text

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

John Frater, Katie Ewer, Ane Ogbe et al. · The Lancet HIV · 2021 · 253 citations · Full text

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern

Donal Skelly, Adam Harding, Javier Gilbert‐Jaramillo et al. · Nature Communications · 2021 · 188 citations · Full text

T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

Adrienn Angyal, Stéphanie Longet, Shona C. Moore et al. · The Lancet Microbe · 2021 · 174 citations · Full text

Vaccinology, Vaccination, Immunology +6

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

Ane Ogbe, Barbara Kronsteiner, Donal Skelly et al. · Nature Communications · 2021 · 141 citations · Full text